Skip to main content
Equibles
SPRY $5.23 -2.97%
SPRY logo
SPRY · ARS Pharmaceuticals, Inc.
Track SPRY — free

Use SPRY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SPRY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.23 -0.16 (-2.97%) At close · Sep 9
Russell 2000 member Rebalance outlook locked
Market Cap
$558.89M
Shares
99.45M
All earnings calls

Earnings call · FY2024 Q2

ARS Pharmaceuticals, Inc. (SPRY) Q2 2024 Earnings Call

Concluded Aug 9, 2024
Aug 9, 2024 0 turns
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $500,000 +4900% YoY
Diluted EPS -$0.13
Net income -$12.52M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 6, 2024 10-Q report Filed Aug 6, 2024

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Revenue Under Collaboration Agreements$500,000
Revenue Under Supply Agreements$0
Product$0
Full-screen source Call document

SPRY transcript alerts

ARS Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →